Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase

被引：27

作者：

Selness, Shaun R. ^{[1
]}

Devraj, Rajesh V. ^{[1
]}

Monahan, Joseph B. ^{[2
]}

Boehm, Terri L. ^{[1
]}

Walker, John K. ^{[1
]}

Devadas, Balekudru ^{[1
]}

Durley, Richard C. ^{[1
]}

Kurumbail, Ravi ^{[3
]}

Shieh, Huey ^{[3
]}

Xing, Li ^{[3
]}

Hepperle, Michael ^{[1
]}

Rucker, Paul V. ^{[1
]}

Jerome, Kevin D. ^{[1
]}

Benson, Alan G. ^{[1
]}

Marrufo, Laura D. ^{[1
]}

Madsen, Heather M. ^{[1
]}

Hitchcock, Jeff ^{[1
]}

Owen, Tom J. ^{[1
]}

Christie, Lance ^{[1
]}

Promo, Michele A. ^{[1
]}

Hickory, Brian S. ^{[1
]}

Alvira, Edgardo ^{[1
]}

Naing, Win ^{[1
]}

Blevis-Bal, Radhika ^{[1
]}

机构：

[1] Pfizer Corp, Dept Med Chem, Chesterfield, MO 63017 USA

[2] Pfizer Corp, Inflammat Biol, Chesterfield, MO 63017 USA

[3] Pfizer Corp, Struct & Computat Chem, Chesterfield, MO 63017 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 20期

关键词：

p38; kinase; Pyridinones; RHEUMATOID-ARTHRITIS;

D O I：

10.1016/j.bmcl.2009.08.082

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The identification and evolution of a series of potent and selective p38 inhibitors is described. p38 inhibitors based on a N-benzyl pyridinone high-throughput screening hit were prepared and their SAR explored. Their design was guided by ligand bound co-crystals of p38 alpha. These efforts resulted in the identification of 12r and 19 as orally active inhibitors of p38 with significant efficacy in both acute and chronic models of inflammation. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5851 / 5856

页数：6

共 50 条

[1] Substituted isoxazoles as potent inhibitors of p38 MAP kinase
Laufer, Stefan A.
Margutti, Simona
Fritz, Martina D.
CHEMMEDCHEM, 2006, 1 (02) : 197 - 207
[2] Discovery of Pyridazinopyridinones as Potent and Selective p38 Mitogen-Activated Protein Kinase Inhibitors
Wu, Bin
Wang, Hui-Ling
Pettus, Liping
Wurz, Ryan P.
Doherty, Elizabeth M.
Henkle, Bradley.
McBride, Helen J.
Saris, Christiaan J. M.
Wong, Lu Min
Plant, Matthew H.
Sherman, Lisa
Lee, Matthew R.
Hsieh, Faye
Tasker, Andrew S.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (17) : 6398 - 6411
[3] Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase
Jerome, Kevin D.
Hepperle, Michael E.
Walker, John K.
Xing, Li
Devraj, Rajesh V.
Benson, Alan G.
Baldus, John E.
Selness, Shaun R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (10) : 3146 - 3149
[4] Potent inhibitors of the map kinase p38
Henry, JR
Rupert, KC
Dodd, JH
Turchi, IJ
Wadsworth, SA
Cavender, DE
Schafer, PH
Siekierka, JJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3335 - 3340
[5] Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold
Herberich, Brad
Cao, Guo-Qiang
Chakrabarti, Partha P.
Falsey, James R.
Pettus, Liping
Rzasa, Robert M.
Reed, Anthony B.
Reichelt, Andreas
Sham, Kelvin
Thaman, Maya
Wurz, Ryan P.
Xu, Shimin
Zhang, Dawei
Hsieh, Faye
Lee, Matthew R.
Syed, Rashid
Li, Vivian
Grosfeld, David
Plant, Matthew H.
Henkle, Bradley
Sherman, Lisa
Middleton, Scot
Wong, Lu Min
Tasker, Andrew S.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) : 6271 - 6279
[6] Substituted pyrazoles as p38 kinase inhibitors
EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (07) : 975 - 979
[7] Discovery of highly selective inhibitors of p38α
Popa-Burke, I
Birkos, S
Blackwell, L
Cheatham, L
Clark, J
Dickson, JK
Galasinski, S
Janzen, WP
Mendoza, J
Miller, JL
Mohney, RP
Steed, PM
Hodge, CN
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) : 941 - 951
[8] Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase
Cumming, JG
McKenzie, CL
Bowden, SG
Campbell, D
Masters, DJ
Breed, J
Jewsbury, PJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5389 - 5394
[9] Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
Devadas, Balekudru
Selness, Shaun R.
Xing, Li
Madsen, Heather M.
Marrufo, Laura D.
Shieh, Huey
Messing, Dean M.
Yang, Jerry Z.
Morgan, Heidi M.
Anderson, Gary D.
Webb, Elizabeth G.
Zhang, Jian
Devraj, Rajesh V.
Monahan, Joseph B.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (13) : 3856 - 3860
[10] Imidazopyrimidines, potent inhibitors of p38 MAP kinase
Rupert, KC
Henry, JR
Dodd, JH
Wadsworth, SA
Cavender, DE
Olini, GC
Fahmy, B
Siekierka, JJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 347 - 350

← 1 2 3 4 5 →